S'identifier

Kathleen A. Maguire-Zeiss

Department of Neuroscience

Georgetown University Medical Center

BIOGRAPHY

Kathleen A. Maguire-Zeiss has not added Biography.

If you are Kathleen A. Maguire-Zeiss and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Somatic mosaic approaches and the aging brain.

Neurobiology of aging Sep-Oct, 2002 | Pubmed ID: 12392799

Convergent pathobiologic model of Parkinson's disease.

Annals of the New York Academy of Sciences Jun, 2003 | Pubmed ID: 12846984

Safety of viral vectors for neurological gene therapies.

Current opinion in molecular therapeutics Oct, 2004 | Pubmed ID: 15537048

Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?

Brain research. Molecular brain research Mar, 2005 | Pubmed ID: 15790526

Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector.

Molecular therapy : the journal of the American Society of Gene Therapy Mar, 2006 | Pubmed ID: 16412694

Identification of human alpha-synuclein specific single chain antibodies.

Biochemical and biophysical research communications Nov, 2006 | Pubmed ID: 16973126

Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.

Brain research Feb, 2007 | Pubmed ID: 17196186

Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium.

Neurobiology of aging Nov, 2008 | Pubmed ID: 17521776

Synuclein activates microglia in a model of Parkinson's disease.

Neurobiology of aging Nov, 2008 | Pubmed ID: 17537546

Gazing into the future: Parkinson's disease gene therapeutics to modify natural history.

Experimental neurology Jan, 2008 | Pubmed ID: 18035353

alpha-Synuclein: a therapeutic target for Parkinson's disease?

Pharmacological research : the official journal of the Italian Pharmacological Society Nov-Dec, 2008 | Pubmed ID: 18840530

Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology Sep, 2009 | Pubmed ID: 18931916

Mutant alpha-synuclein overexpression mediates early proinflammatory activity.

Neurotoxicity research Oct, 2009 | Pubmed ID: 19526281

Gene therapy in Parkinson's disease: rationale and current status.

CNS drugs Mar, 2010 | Pubmed ID: 20155994

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996) Aug, 2010 | Pubmed ID: 20549523

Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability.

The European journal of neuroscience Jul, 2010 | Pubmed ID: 20550572

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

Nature medicine Sep, 2010 | Pubmed ID: 20729864

Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.

Neurotoxicity research Nov, 2011 | Pubmed ID: 21735318

α-Synuclein Alters Toll-Like Receptor Expression.

Frontiers in neuroscience , 2011 | Pubmed ID: 21747756

Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease.

Parkinsonism & related disorders Jan, 2012 | Pubmed ID: 22166424

Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine.

Current HIV research Jul, 2012 | Pubmed ID: 22591362

Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology Mar, 2013 | Pubmed ID: 23054368

Parkinson's disease.

Sub-cellular biochemistry , 2012 | Pubmed ID: 23225012

Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson's Disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics Aug, 2013 | Pubmed ID: 23963789

INSTITUTIONS

Georgetown University Medical Center

JOVE ARTICLES

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Stefano G. Daniele¹,

Amanda A. Edwards¹,

Kathleen A. Maguire-Zeiss¹

¹Department of Neuroscience, Georgetown University Medical Center

Immunology and Infection

Confidentialité

Conditions d'utilisation

Politiques

Contactez-nous

RECOMMANDER À LA BIBLIOTHÈQUE

NEWSLETTERS JoVE

Recherche

JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives

Enseignement

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Faculty Site

Auteurs

Vue d'ensemble
Processus de publication
Comité éditorial
Domaines et politique de publication
Révision par les pairs
FAQ
Soumettre

Bibliothécaires

Vue d'ensemble
Témoignages
Abonnements
Accès
Ressources
Conseil consultatif des bibliothèques
FAQ

À PROPOS DE JoVE

Vue d'ensemble
Direction
Blog
JoVE Help Center

Kathleen A. Maguire-Zeiss

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Neuroscience

Georgetown University Medical Center

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Department of Neuroscience